Because of complex genetic mutations, treating blood cancers is particularly challenging and requires specialized therapies. In the intricate world of leukemia, lymphoma and myeloma, each breakthrough achieved through clinical trials brings scientists and clinicians a step closer to transforming standards of care for patients around the world. Dr. Mikkael Sekeres, chief of the Division of Hematology at the Sylvester Comprehensive Cancer Center, provides insight into these diseases and shares the current research landscape in the latest episode of Inside U Miami Medicine.